SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-21-092731
Filing Date
2021-03-24
Accepted
2021-03-24 16:56:26
Documents
11
Effectiveness Date
2021-03-24

Document Format Files

Seq Description Document Type Size
1 S-3ASR d14389ds3asr.htm S-3ASR 513332
2 EX-1.2 d14389dex12.htm EX-1.2 160346
3 EX-4.6 d14389dex46.htm EX-4.6 322533
4 EX-4.8 d14389dex48.htm EX-4.8 98528
5 EX-4.9 d14389dex49.htm EX-4.9 101773
6 EX-4.10 d14389dex410.htm EX-4.10 87834
7 EX-5.1 d14389dex51.htm EX-5.1 28729
8 EX-23.1 d14389dex231.htm EX-23.1 1532
9 GRAPHIC g14389g01k00.jpg GRAPHIC 40843
10 GRAPHIC g14389g0319162859253.jpg GRAPHIC 2538
11 GRAPHIC g14389g18y00.jpg GRAPHIC 82256
  Complete submission text file 0001193125-21-092731.txt   1481334
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-254661 | Film No.: 21768843
SIC: 2834 Pharmaceutical Preparations